Get 30% off on our Global Market Reports with code ONLINE30 – Hurry, limited time offer!
What Is the Estimated Market Size of the Juvenile Macular Degeneration Treatment Market In 2029?
The market for treating juvenile macular degeneration has experienced substantial growth in recent years. The market is projected to expand from $1.28 billion in 2024 to $1.39 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. Growth during the historic period is due to factors such as the increased occurrence of genetic eye diseases, more investment in ophthalmology research, heightened attention on eye care for children, increasing instances of vision problems in children, and the advancing integration of artificial intelligence in eye care diagnostics.
There is a prediction for substantial expansion in the juvenile macular degeneration treatment market in the foreseeable future. This market is set to escalate to $1.88 billion in 2029 with an 8.0% Compound Annual Growth Rate (CAGR). Factors contributing to this projected growth during the forecast period include an increasing elderly population, the emergence of ophthalmic biotechnology startups, heightened focus on targeted drug delivery systems, more clinical trials, and amplified investments in gene therapy. Foreseeable trends during this period encompass advancements in genetic testing, the progress of gene therapies, stem cell research, regulatory backing for innovative therapies, and the adoption of personalized medicine tactics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23433&type=smp
Which Primay Drivers Are Accelerating Growth in the Juvenile Macular Degeneration Treatment Market?
The expansion of the juvenile macular degeneration treatment market is poised to get influenced by the growing instances of retinal disorders. These disorders, linked to the retina’s functionality – the light-sensitive aspect of the eye, can prompt vision deterioration or even loss. Escalating diabetes instances contribute significantly to these disorders, causing conditions such as diabetic retinopathy, resulting in progressive retina damage. Treatments targeted towards juvenile macular degeneration aid to control retinal disorders by safeguarding vision through early treatment methods, which are extremely beneficial for young patients. As indicated by a report from Retina Australia, a non-profit organization from Australia, in November 2024, approximately 19,000 people or around 1 in every 1,380 individuals, are presumed to be affected by inherited retinal disease (IRD) in Australia. Moreover, as per the National Eye Institute, a health institute based in the US, the count for Americans dealing with advanced age-related macular degeneration (AMD) is projected to rise from the present 2.1 million to somewhere around 3.7 million by 2030. Hence, the climbing occurrences of retinal disorders act as a significant driving factor for the upward trend in the juvenile macular degeneration treatment market.
Which Primary Segments of the Juvenile Macular Degeneration Treatment Market Are Driving Growth and Industry Transformations?
The juvenile macular degeneration treatment market covered in this report is segmented –
1) By Type: Wet Age-Related Macular Degeneration, Dry Age-Related Macular Degeneration
2) By Treatment: Devices, Drugs, Surgery
3) By Application: Vision Preservation, Disease Management, Symptom Relief, Preventive Care, Clinical Trials
4) By Sales Channel: Hospitals, Ambulatory Surgical Centres, Other Sales Channel
Subsegments:
1) By Wet Age-Related Macular Degeneration: Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapy, Photodynamic Therapy (PDT), Laser Therapy
2) By Dry Age-Related Macular Degeneration: Nutritional Supplements, Gene Therapy, Stem Cell Therapy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=23433&type=smp
Which Regions Are Key Players in the Growth of the Juvenile Macular Degeneration Treatment Market?
North America was the largest region in the juvenile macular degeneration treatment market in 2024. The regions covered in the juvenile macular degeneration treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Juvenile Macular Degeneration Treatment Market?
Major corporations in the juvenile macular degeneration treatment market are concentrating their efforts on pioneering innovative solutions, such as dual adeno-associated viral (AAV) vectors, with the aim of advancing gene therapy delivery and augmenting the effectiveness of the treatment for juvenile macular degeneration patients. The function of a dual AAV vector in gene therapy is to utilise two AAV vectors for the delivery of therapeutic genes which are too large to be packed within one AAV. To illustrate, in March 2025, SpliceBio, a biotechnology firm based in Spain, revealed the first patient dosage in its Phase 1/2 ASTRA study for SB-007. SB-007 is a dual AAV vector gene therapy constructed to restore the full expression of the ABCA4 protein. The objective of this therapy is to offer a potential cure for juvenile macular degeneration, also known as Stargardt disease. This is an inherited retinal disorder which currently has no approved treatments, aiming to assist all patients regardless of the type of mutations they have. This progress marks a considerable advancement towards the creation of effective gene therapies for uncommon retinal disorders.
View the full report here:
What Parameters Are Used to Define the Juvenile Macular Degeneration Treatment Market?
Juvenile macular degeneration (stargardt disease) treatment refers to a range of strategies aimed at managing vision loss and improving quality of life for individuals affected by this genetic eye disorder. It is caused by genetic mutations that damage the macula, the central part of the retina, leading to gradual vision loss and difficulty with tasks like reading and recognizing faces.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23433
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model